Eli Lilly and Company
LLY● 市場休市$1,186.10+0.11%
Healthcare
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications.
價格圖表
右方向鍵：此組的更多工具
右方向鍵：此組的更多工具
右方向鍵：此組的更多工具
右方向鍵：此組的更多工具
右方向鍵：此組的更多工具
右方向鍵：此組的更多工具
右方向鍵：此組的更多工具
載入圖表中…
概覽
形態分析 (Basic+)
K線形態識別在 Basic 及以上方案中可用。 升級
關於 Eli Lilly and Company
Eli Lilly and Company（LLY）屬於 Healthcare 板塊（Drug Manufacturers - General）。 該股在 NYSE 上市。 市值：$1.1兆。 52 周區間：$725.31 – $1,292.65。
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications.
閱讀更多
This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity.
In oncology, Eli Lilly offers a robust portfolio targeting various cancers.